Breastfeeding Roadmap in Primiparous Women

NCT ID: NCT06918574

Last Updated: 2025-07-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

74 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-04-15

Study Completion Date

2025-07-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The effect of the breastfeeding roadmap used in primiparous mothers on breastfeeding self-efficacy perception and breastfeeding success will be evaluated.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The research was planned as a randomized controlled experimental study. Mothers who meet the inclusion criteria and agree to participate in the study will be assigned to the intervention and control groups according to the randomization list.

A total of 74 primiparous mothers who gave birth, 37 in the intervention group and 37 in the control group, will be included in the study.

In addition to the routine breastfeeding education given by the clinic's education nurse, the mothers in the intervention group will also receive a "Breastfeeding Roadmap" education poster prepared by the researchers, which will be hung on the wall of their rooms. The researcher will introduce the Breastfeeding Roadmap to the mothers and provide information on breastfeeding. Routine hospital breastfeeding education will receive to mothers in the control group after childbirth.

Data Collection Pre-Test; Introductory Information Form, Breastfeeding Self-Efficacy Scale Short-Form, LATCH Breastfeeding Assessment Tool will be collected within the first hour after birth (before Breastfeeding Roadmap breastfeeding education and hospital routine breastfeeding education were implemented) Post-test; Breastfeeding Self-Efficacy Scale Short-Form, LATCH Breastfeeding Assessment Tool will be collected at least two hours before mothers are discharged from the hospital (the discharge period usually varies between 24 and 48 hours).

At the end of the study, the results of the mothers in the experimental and control groups will be evaluated.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breastfeeding Self Efficacy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention group

In addition to the routine breastfeeding education given by the clinic's education nurse, the mothers in the intervention group will also receive a "Breastfeeding Roadmap" education poster prepared by the researchers, which will be hung on the wall of their rooms. The researcher will introduce the Breastfeeding Roadmap to the mothers and provide information on breastfeeding.

Group Type EXPERIMENTAL

Breastfeeding Education with Breastfeeding Roadmap

Intervention Type OTHER

Information about the "Breastfeeding Roadmap" prepared by the researchers will be explained to the mothers in the intervention group and hung in poster rooms.

Control group

The control group of the study will receive routine breastfeeding education provided by the clinic's education nurse.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Breastfeeding Education with Breastfeeding Roadmap

Information about the "Breastfeeding Roadmap" prepared by the researchers will be explained to the mothers in the intervention group and hung in poster rooms.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Volunteer to participate in the study,
* Primiparous,
* Giving birth at 37 weeks of gestation or later,
* No condition preventing breastfeeding,
* No condition preventing breastfeeding in the baby,
* At least primary school graduate,
* Mothers aged 18 and over

Exclusion Criteria

* Those who have given birth to multiple pregnancies,
* Those who received general anesthesia for Caesarean section,
* Those who have any chronic disease, diagnosed mental or psychiatric illness history,
* Those who have a history of preeclampsia, eclampsia and gestational diabetes,
* Those whose babies are in intensive care after birth
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Selcuk University Scientific Research Projects Unit

UNKNOWN

Sponsor Role collaborator

Selcuk University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ebru Bekmezci

PhD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ebru Bekmezci PhD

Role: PRINCIPAL_INVESTIGATOR

Selcuk University

Hediye Karakoç PhD

Role: PRINCIPAL_INVESTIGATOR

KTO Karatay University

Halime Esra Meram PhD

Role: PRINCIPAL_INVESTIGATOR

Selcuk University

Jule Eriç Horasanlı Doctor, ASSOCIATE PROFESSOR

Role: PRINCIPAL_INVESTIGATOR

Necmettin Erbakan University Medical Faculty Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Necmettin Erbakan University Faculty of Medicine Hospital

Konya, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024/048

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.